Clinical Microbiology Procedures Handbook

Section 16: Quality Assurance, Quality Control, Laboratory Records, and Water Quality

16.3 Verification and Validation of Test System Performance Specifications

Authors:
Last Updated:2023

NOTICE TO ALL USERS

ClinMicroNow has moved to a new home. As of January 15th, 2025 ClinMicroNow can be found on Wiley Online Library here. This site will no longer be updated and will be decommissioned in March 2025.

Current subscribers who already have a registration for Wiley Online Library have been set up for access to the new version. All other subscribers will receive instructions on how to activate their access for ClinMicroNow on Wiley Online Library. If you experience any issues trying to access ClinMicroNow please contact [email protected].

New subscribers: Please contact Wiley Online Library sales for purchasing options.

ACCESS CLINMICRONOW ON WILEY ONLINE LIBRARY

I. Introduction

Clinical laboratory testing in the United States is regulated by the Centers for Medicare and Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) (1). CLIA provides…

II. Definitions

510(k): Also known as a premarket notification. 510(k) submissions to the FDA are used for medical devices being introduced into the market for the first time that are substantially equivalent…

III. Specimen Collection, Transport, and Handling

Patient samples must be residual samples that are no longer needed for testing. Prospective collection of specimens for the purpose of test verification or validation may require informed consent and approval…

IV. Materials

Required materials will vary depending on the systems being assessed. Refer to sections below for selective examples.

V. Quality Control (QC)

It is suggested that QC be performed prior to verification or validation of a new test system. Following verification/validation of a test system, routine QC should be performed as part of quality assurance…

VI. Procedure

A new system is the new method being introduced to the laboratory for the first time. Examples of a new system may include: A method or instrument being brought into or developed…

VII. Procedures for Special Systems and Scenarios

Precision and accuracy must be verified for a new MIS being introduced into a laboratory. Reportable range is not applicable for these systems. However, for commercial systems the manufacturer…

VIII. Data Analysis

Basic statistics lessons at www.westgard.com provide in‐depth explanations of these topics. SD measures imprecision by determining dispersion of values around the mean…

IX. Reporting

All reports from a validated laboratory‐developed test should include a disclaimer stating, “This test was developed and its performance characteristics determined by…

X. Additional Considerations

CLIA requires the establishment or verification of performance specifications prior to the release of any patient test results. An acceptable study must be signed off by the laboratory director or qualified designee before the evaluation…

cover

Section Editor: Linoj Samuel

Editors in Chief: Amy L. Leber and Carey-Ann D. Burnham

Citation Information
Copyright © 2023 by ASM Press. ASM Press is a registered trademark of the American Society for Microbiology. All rights reserved. No part of this publication may be reproduced or transmitted in whole or in part or reutilized in any form or by any means, electronic or mechanical, including photocopying and recording, or by any information storage and retrieval system, without permission in writing from the publisher.